United States· US:0270-7400_18b52319-bd56-4fce-b6a4-358e3f8a3a04
Iomeron
A iomeprol product containing iomeprol, registered in United States by BRACCO DIAGNOSTICS INC. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Iomeprol is registered in 14 of 19 countries.
Countries holding a registration under ATC V08AB10 (iomeprol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Iomeprol · ATC V08AB10
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- IOMEPROL
- Manufacturer
- BRACCO DIAGNOSTICS INC
- Country
- United States (US)
- ATC code
- V08AB10
- ATC class
- Iomeprol
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11027074001356 BOTTLE, GLASS in 1 BOX (0270-7400-13) / 100 mL in 1 BOTTLE, GLASS
- ndc110270740016100 BOTTLE, GLASS in 1 BOX (0270-7400-16) / 100 mL in 1 BOTTLE, GLASS
- ndc11027074002030 BOTTLE, GLASS in 1 BOX (0270-7400-20) / 200 mL in 1 BOTTLE, GLASS
- ndc110270-7400-16
- ndc110270-7400-20
- ndc110270-7400-13
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iomeprol in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIomeron 250 mg/mlBracco Imaging Deutschland
- CzechiaIOMERONBracco Imaging Deutschland GmbH, Konstanz
- United KingdomIomeron 250 solution for injection 150ml bottlesBracco UK Ltd
- Japanイオメプロールブラッコ・ジャパン
- GermanyImeronBracco Imaging Deutschland Gmbh
- FinlandIomeronBracco Imaging SpA
- SwedenIomeron 150 mg I/ml Injektionsvätska, lösningBracco Imaging SpA
- IrelandIomeron 150 mgI/ml Solution for InjectionBracco Imaging spa
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Iomeron
- Belgium · Iomeron
- Bulgaria · Iomeron
- Czechia · Iomeron
- Germany · Imeron
- Denmark · Iomeron
- Spain · Iomeron
- Finland · Iomeron
- France · Iomeron
- United Kingdom (Northern Ireland) · Iomeron
- Greece · Iomeron
- Croatia · Iomeron
- Hungary · Iomeron
- Ireland · Iomeron
- Italy · Iomeron
- Luxembourg · Iomeron
- Netherlands · Iomeron
- Norway · Iomeron
- Poland · Iomeron
- Portugal · Iomeron
- Romania · Iomeron
- Sweden · Iomeron
- Slovenia · Iomeron
- Slovakia · Iomeron 150, Iomeron 200
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/69cbc9d5-315e-45c2-8f7f-1a0ac6dfbced GET /v1/drugs/69cbc9d5-315e-45c2-8f7f-1a0ac6dfbced?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVASCULAR",
"source": "ndc",
"strength": "816",
"substance": "IOMEPROL",
"productndc": "0270-7400",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE"
}See everything about iomeprol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.